Epithelial Ovarian Cancer Patients and Clinicopathological Features and Survival: A Comparison of Outcomes of Two Age Cohorts in Bangladesh — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Epithelial Ovarian Cancer Patients and Clinicopathological Features and Survival: A Comparison of Outcomes of Two Age Cohorts in Bangladesh
Gynecological Oncology Department, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh
,
Gynecological Oncology Department, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh
,
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, USA
1 Gynecological Oncology Department, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh
2 Gynecological Oncology Department, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh
3 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, USA
Objective: This study compared the clinicopathologic characteristics and overall survival of epithelial ovarian carcinoma in women younger versus older than 45 years in Bangladesh. Methods: A retrospective analysis identified 129 epithelial ovarian carcinoma patients who were admitted to the National Institute of Cancer Research and Hospital, in Dhaka, Bangladesh from 2016 through 2017 for surgery. These patients were grouped into two categories : the younger group (≤45 years) and the older group (>45 years) . Clinicopathological features of epithelial ovarian carcinoma were analyzed in each age group. Cox proportional hazards model identified factors affecting survival and Kaplan-Meier survival curves with log rank test compared outcomes for each age group. Results : The median age of the 129 women was 46 years (IQR: 38, 56) and median time of follow-up was 9 months (inter-quartile range: 4, 26.5). We found a significant difference in the CA-125 level (p < 0.044), age of menopause (p < 0.001), follow-up duration (p < 0.016), disease outcome (p < 0.005) and histopathological type (p < 0.021) between the two groups. No significant differences were found in breakdown of Federation of Gynecology and Obstetrics (FIGO) stage of the disease. There was a significant difference in overall survival between the patients of two groups (p = 0.021) where there was a higher probability of death among the older cohort. The 5-year overall survival rate s for the younger age versus older group were 34.0%, and 11.7% respectively. Independent prognostic factors by univariate analysis for the overall survival were age, FIGO stage, preoperative CA-125 and CEA level. However, when controlling for stage, survival was similar between age cohorts. Conclusions: Our data suggests that women in Bangladesh with epithelial ovarian cancer who are under the age of 45 years have a different clinical profile and better overall survival than women in the older age cohort.
Webb, P.M. and Jordan, S.J. (2017) Epidemiology of Epithelial Ovarian Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 41, 3-14. https://doi.org/10.1016/j.bpobgyn.2016.08.006
Kaku, T., Ogawa, S., Kawano, Y., Ohishi, Y., Kobayashi, H., Hirakawa, T. and Nakano, H. (2003) Histological Classification of Ovarian Cancer. Medical Electron Microscopy, 36, 9-17. https://doi.org/10.1007/s007950300002
Yoshikawa, N., Kajiyama, H., Mizuno, M., Shibata, K., Kawai, M., Nagasaka, T. and Kikkawa, F. (2014) Clinicopathologic Features of Epithelial Ovarian Carcinoma in Younger vs. Older Patients: Analysis in Japanese Women. Journal of Gynecologic Oncology, 25, 118-123. https://doi.org/10.3802/jgo.2014.25.2.118
Coleridge, S.L., Bryant, A., Kehoe, S. and Morrison, J. (2021) Neoadjuvant Chemotherapy before Surgery versus Surgery Followed by Chemotherapy for Initial Treatment in Advanced Ovarian Epithelial Cancer. Cochrane Database of Systematic Reviews, 7, CD005343. https://doi.org/10.1002/14651858.CD005343.pub6
Kalam, F., Pervin, S., Joy, K., Islam, J. and Goodman, A. (2021) Neoadjuvant Chemotherapy Followed by Surgery versus Primary Surgery in Advanced Epithelial Ovarian Cancer: A Review of Outcomes at National Institute of Cancer Research Hospital in Bangladesh. Journal of Cancer Therapy, 12, 621-633. https://doi.org/10.4236/jct.2021.1211054
Karimi-Zarchi, M., Mortazavizadeh, S.M., Bashardust, N., Zakerian, N., Zaidabadi, M., Yazdian-Anari, P. and Teimoori, S. (2015) The Clinicopathologic Characteristics and 5-Year Survival Rate of Epithelial Ovarian Cancer in Yazd, Iran. Electronic Physician Journal, 7, 1399-1406.
Hanatani, M., Yoshikawa, N., Yoshida, K., Tamauchi, S., Ikeda, Y., Nishino, K., Niimi, K., Suzuki, S., Kawai, M., Kajiyama, H. and Kikkawa, F. (2020) Impact of Age on Clinicopathological Features and Survival of Epithelial Ovarian Neoplasms in Reproductive Age. International Journal of Clinical Oncology, 25, 187-194. https://doi.org/10.1007/s10147-019-01550-7
Tanaka, Y., Terai, Y., Tanabe, A., Sasaki, H., Sekijima, T., Fujiwara, S., Yamashita, Y., Kanemura, M., Ueda, M., Sugita, M., Franklin, W.A. and Ohmichi, M. (2011) Prognostic Effect of Epidermal Growth Factor Receptor Gene Mutations and the Aberrant Phosphorylation of Akt and ERK in Ovarian Cancer. Cancer Biology & Therapy, 11, 50-57. https://doi.org/10.4161/cbt.11.1.13877
Chan, J.K., Urban, R., Cheung, M.K., Osann, K., Shin, J.Y., Husain, A., Teng, N.N., Kapp, D.S., Berek, J.S. and Leiserowitz, G.S. (2006) Ovarian Cancer in Younger vs Older Women: A Population-Based Analysis. British Journal of Cancer, 95, 1314-1320.
O’Malley, C.D., Cress, R.D., Campleman, S.L. and Leiserowitz, G.S. (2003) Survival of Californian Women with Epithelial Ovarian Cancer, 1994-1996: A Population-Based Study. Gynecologic Oncology, 91, 608-615. https://doi.org/10.1016/j.ygyno.2003.08.010
Berek, J.S., Kehoe, S.T., Kumar, L. and Friedlander, M. (2018) Cancer of the Ovary, Fallopian Tube, and Peritoneum. International Journal of Gynecology & Obstetrics, 143, 59-78. https://doi.org/10.1002/ijgo.12614
National Comprehensive Cancer Network (2023) Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer (Version 3.2023). https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1453
Chiofalo, B., Bruni, S., Certelli, C., Sperduti, I., Baiocco, E. and Vizza, E. (2019) Primary Debulking Surgery vs. Interval Debulking Surgery for Advanced Ovarian Cancer: Review of the Literature and Meta-Analysis. Minerva Medica, 110, 330-340. https://doi.org/10.23736/S0026-4806.19.06078-6
BMJ (2023) 8. The Chi Squared Tests. https://www.bmj.com/about-bmj/resources-readers/publications/statistics-square-one/8-chi-squared-tests
Hoffman, J.I.E. (2019) Analysis of Variance. I. One-Way. In: Hoffman, J.I.E., Ed., Basic Biostatistics for Medical and Biomedical Practitioners (Second Edition), Academic Press, Cambridge, 391-417. https://doi.org/10.1016/B978-0-12-817084-7.00025-5 https://www.sciencedirect.com/science/article/pii/B9780128170847099939
Goel, M.K., Khanna, P. and Kishore, J. (2010) Understanding Survival Analysis: Kaplan-Meier Estimate. International Journal of Ayurveda Research, 1, 274-278.
Bland, J.M. and Altman, D.G. (2004) The Logrank Test. The BMJ, 328, 1073. https://doi.org/10.1136/bmj.328.7447.1073
Dinca, A.L., Bîrla, R.D., Dinca, V.G., Marica, C., Panaitescu, E. and Constantinoiu, S. (2020) Prognostic Factors in Advanced Ovarian Cancer—A Clinical Trial. Chirurgia, 115, 50-62. https://doi.org/10.21614/chirurgia.115.1.50
Verleye, L., Ottevanger, P.B., van der Graaf, W., Reed, N.S. and Vergote, I. (2009) Gynaecological Cancer Group (GCG) of European Organisation for Research and Treatment of Cancer (EORTC). EORTC-GCG Process Quality Indicators for Ovarian Cancer Surgery. European Journal of Cancer, 45, 517-526. https://doi.org/10.1016/j.ejca.2008.09.031
Bachmann, R., Rothmund, R., Krämer, B., Brucker, S.Y., Königsrainer, A., Königsrainer, I., Beckert, S., Staebler, A., NguyenHuu, P., Grischke, E., Wallwiener, D. and Bachmann, C. (2015) The Prognostic Role of Optimal Cytoreduction in Advanced, Bowel Infiltrating Ovarian Cancer. Journal of Investigative Surgery, 28, 160-166. https://doi.org/10.3109/08941939.2014.994794
Vergote, I., Amant, F., Kristensen, G., Ehlen, T., Reed, N.S. and Casado, A. (2011) Primary Surgery or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery in Advanced Ovarian Cancer. European Journal of Cancer, 47, S88-S92. https://doi.org/10.1016/S0959-8049(11)70152-6
Fagotti, A., Ferrandina, M.G., Vizzielli, G., Pasciuto, T., Fanfani, F., Gallotta, V., Margariti, P.A., Chiantera, V., Costantini, B., Gueli Alletti, S., Cosentino, F. and Scambia, G. (2020) Randomized Trial of Primary Debulking Surgery versus Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer (SCORPION-NCT01461850). International Journal of Gynecologic Cancer, 30, 1657-1664. https://doi.org/10.1136/ijgc-2020-001640
Uno, K., Yoshikawa, N., Tazaki, A., Ohnuma, S., Kitami, K., Iyoshi, S., Mogi, K., Yoshihara, M., Koya, Y., Sugiyama, M., Tamauchi, S., Ikeda, Y., Yokoi, A., Kikkawa, F., Kato, M. and Kajiyama, H. (2022) Significance of Platinum Distribution to Predict Platinum Resistance in Ovarian Cancer after Platinum Treatment in Neoadjuvant Chemotherapy. Scientific Reports, 12, Article No. 4513. https://doi.org/10.1038/s41598-022-08503-7
Liu, Y.L., Zhou, Q.C., Iasonos, A., Chi, D.S., Zivanovic, O., Sonoda, Y., Gardner, G., Broach, V., O’Cearbhaill, R., Konner, J.A., Grisham, R., Aghajanian, C.A., Abu-Rustum, N.R., Tew, W. and Long Roche, K. (2020) Pre-Operative Neoadjuvant Chemotherapy Cycles and Survival in Newly Diagnosed Ovarian Cancer: What Is the Optimal Number? A Memorial Sloan Kettering Cancer Center Team Ovary Study. International Journal of Gynecologic Cancer, 30, 1915-1921. https://doi.org/10.1136/ijgc-2020-001641
Peres, L.C., Cushing-Haugen, K.L., Köbel, M., Harris, H.R., Berchuck, A., Rossing, M.A., Schildkraut, J.M. and Doherty, J.A. (2019) Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. Journal of the National Cancer Institute, 111, 60-68. https://doi.org/10.1093/jnci/djy071
Matz, M., Coleman, M.P., Carreira, H., Salmerón, D., Chirlaque, M.D., Allemani, C. and CONCORD Working Group (2017) Worldwide Comparison of Ovarian Cancer Survival: Histological Group and Stage at Diagnosis (CONCORD-2). Gynecologic Oncology, 144, 396-404.
Fuh, K.C., Shin, J.Y., Kapp, D.S., Brooks, R.A., Ueda, S., Urban, R.R., Chen, L.M. and Chan, J.K. (2015) Survival Differences of Asian and Caucasian Epithelial Ovarian Cancer Patients in the United States. Gynecologic Oncology, 136, 491-497. https://doi.org/10.1016/j.ygyno.2014.10.009
Trillsch, F., Woelber, L., Eulenburg, C., Braicu, I., Lambrechts, S., Chekerov, R., van Nieuwenhuysen, E., Speiser, P., Zeimet, A., Castillo-Tong, D.C., Concin, N., Zeillinger, R., Vergote, I., Mahner, S. and Sehouli, J. (2013) Treatment Reality in Elderly Patients with Advanced Ovarian Cancer: A Prospective Analysis of the OVCAD Consortium. Journal of Ovarian Research, 6, Article No. 42. https://doi.org/10.1186/1757-2215-6-42
Sabatier, R., Calderon Jr, B., Lambaudie, E., Chereau, E., Provansal, M., Cappiello, M.A., Viens, P. and Rousseau, F. (2015) Prognostic Factors for Ovarian Epithelial Cancer in the Elderly: A Case-Control Study. International Journal of Gynecologic Cancer, 25, 815-822. https://doi.org/10.1097/IGC.0000000000000418
Chan, J.K., Loizzi, V., Lin, Y.G., Osann, K., Brewster, W.R. and DiSaia, P.J. (2003) Stages III and IV Invasive Epithelial Ovarian Carcinoma in Younger versus Older Women: What Prognostic Factors Are Important? Obstetrics & Gynecology, 102, 156-161. https://doi.org/10.1016/S0029-7844(03)00399-5
Manchana, T., Phoolcharoen, N. and Tantbirojn, P. (2019) BRCA Mutation in High Grade Epithelial Ovarian Cancers. Gynecologic Oncology Reports, 29, 102-105. https://doi.org/10.1016/j.gore.2019.07.007
Afrin, S. and Arifuzzaman, M. (2020) e-Health in Developing Countries: Bangladeshi Perspective. International Journal of Engineering and Advanced Technology, 9, 908-914. https://doi.org/10.35940/ijeat.A1837.029320